Andres I respectfully accept your point of view but disagree that any rerate of significance can occur without consideration of share structure. Sure we have cash and sure trials should be positive for we shareholders but the greater benefit will always be achieved thru prudent capital management. Anyway no more arguing - we agree that IHL is a jewel - let's see how bright it shines
- Forums
- ASX - By Stock
- IHL
- Ann: Clinical Progress on IHL-216A for TBI and CTE
Ann: Clinical Progress on IHL-216A for TBI and CTE, page-28
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online